BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19016035)

  • 1. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
    Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.
    Sakata K; Oouchi A; Nagakura H; Akiba H; Tamakawa M; Koito K; Hareyama M; Asakura K; Satoh M; Ohtani S
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):81-8. PubMed ID: 10758308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
    Terhaard CH; Kal HB; Hordijk GJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
    Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
    Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
    Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
    Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS; Fish B; Fenton JE; Husband DJ
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
    Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiotherapy of T1N0 neoplasms of the glottis. Analysis of the parameters that influence local control].
    Bolner A; Valentini A; Amichetti M; Busana L; Fellin G; Menegotti L; Nassivera E; Pani G; Romano M
    Radiol Med; 1995 Dec; 90(6):804-7. PubMed ID: 8685467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
    Reddy SP; Hong RL; Nagda S; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1389-94. PubMed ID: 17869013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced regeneration response of laryngeal and hypopharyngeal mucosa with accelerated hyperfractionated radiation therapy for glottic cancers.
    Mariya Y; Matsutani H; Abe Y; Nakaji S
    Radiat Med; 1998; 16(6):469-72. PubMed ID: 9929148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
    Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation.
    Okubo M; Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Tachibana I; Koike R; Nishikawa T; Mori K
    Jpn J Clin Oncol; 2010 Oct; 40(10):944-8. PubMed ID: 20534687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.